SEC Company Response from BIOVIE INC. (BIVI, BIVIW) (CIK 0001580149) (BIVI) — Mar 28, 2017
BIOVIE INC. (BIVI, BIVIW) (CIK 0001580149)
Date: March 28, 2017 · CIK: 0001580149 · Accession: 0001520138-17-000110
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-215619
Letter
[BioVie Inc. Letterhead]
March 28, 2017
VIA EDGAR
Suzanne Hayes
Assistant Director, Office of Healthcare and Insurance
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re: BioVie Inc.
Registration Statement on Form S-1
Filed January 19, 2017; amended March 10, 2017 and March 28, 2017
File No. 333-215619
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, BioVie Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of its Registration Statement on Form S-1 (File No. 333-215619) (as amended, the “Registration Statement”) and declare the Registration Statement effective as of Thursday, March 30, 2017, at 4:00 p.m., Eastern time, or as soon as practicable thereafter.
Please contact David Crandall of Hogan Lovells US LLP at (303) 454-2449 with any questions. Also, please notify Mr. Crandall when this request for acceleration has been granted.
Very truly
yours,
BioVie Inc.
Show Raw Text
CORRESP 1 filename1.htm [BioVie Inc. Letterhead] March 28, 2017 VIA EDGAR Suzanne Hayes Assistant Director, Office of Healthcare and Insurance United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: BioVie Inc. Registration Statement on Form S-1 Filed January 19, 2017; amended March 10, 2017 and March 28, 2017 File No. 333-215619 Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, BioVie Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of its Registration Statement on Form S-1 (File No. 333-215619) (as amended, the “Registration Statement”) and declare the Registration Statement effective as of Thursday, March 30, 2017, at 4:00 p.m., Eastern time, or as soon as practicable thereafter. Please contact David Crandall of Hogan Lovells US LLP at (303) 454-2449 with any questions. Also, please notify Mr. Crandall when this request for acceleration has been granted. Very truly yours, BioVie Inc. By: /s/ Jonathan Adams Name: Jonathan Adams Title: Chief Executive Officer cc: David R. Crandall, Esq., Hogan Lovells US LLP